The relationship between C-reactive protein/albumin ratio and mortality in hypertensive patients: A national cohort

Rongting Zhang1, Yani Wang2, Lihua Liao2

  • 1Department of Cardiology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.

Insights

Elevated C-reactive protein to albumin ratio (CAR) in hypertension patients indicates a higher risk of mortality. This inflammatory marker can aid in risk stratification for better hypertension management.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Biomarkers
  • Hypertension Research

Background:

  • Inflammation's role in hypertension prognosis is under investigation.
  • C-reactive protein to albumin ratio (CAR) is a novel inflammatory marker.
  • The association between CAR and mortality in hypertensive individuals requires further study.

Purpose of the Study:

  • To investigate the relationship between the C-reactive protein to albumin ratio (CAR) and mortality risk in patients with hypertension.
  • To determine if CAR can serve as a prognostic indicator in hypertensive individuals.

Main Methods:

  • Analysis of 9561 hypertensive patients.
  • Calculation of C-reactive protein to albumin ratio (CAR).
  • Kaplan-Meier survival analysis and multivariable Cox regression models were used.

Main Results:

  • Higher baseline CAR levels were associated with increased all-cause mortality.
  • Patients in the highest CAR tertile had a 60% increased risk of mortality (HR, 1.60 [95%CI, 1.23-2.09]).
  • P-value < 0.001 indicated statistical significance.

Conclusions:

  • Elevated CAR is linked to a higher risk of all-cause mortality in hypertensive patients.
  • CAR may be a valuable tool for risk stratification in hypertension.
  • Utilizing CAR can help optimize follow-up and treatment strategies for hypertensive individuals.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
118
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
162
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K